New York State Common Retirement Fund Tarsus Pharmaceuticals, Inc. Transaction History
New York State Common Retirement Fund
- $74.6 Billion
- Q4 2024
A detailed history of New York State Common Retirement Fund transactions in Tarsus Pharmaceuticals, Inc. stock. As of the latest transaction made, New York State Common Retirement Fund holds 43,004 shares of TARS stock, worth $1.83 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
43,004
Previous 44,604
3.59%
Holding current value
$1.83 Million
Previous $1.47 Million
62.3%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding TARS
# of Institutions
201Shares Held
40.5MCall Options Held
72.7KPut Options Held
313K-
Black Rock Inc. New York, NY3.27MShares$139 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY3.24MShares$138 Million2.92% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY2.53MShares$108 Million5.35% of portfolio
-
Jennison Associates LLC2.5MShares$106 Million0.09% of portfolio
-
Tang Capital Management LLC San Diego, CA2.25MShares$96 Million9.38% of portfolio
About Tarsus Pharmaceuticals, Inc.
- Ticker TARS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,658,500
- Market Cap $1.13B
- Description
- Tarsus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for ophthalmic conditions. Its lead product candidate is TP-03, a novel therapeutic that is in Phase III for the treatment of blepharitis caused by the infestation of Demodex mites, as well as...